This post may contain affiliate links for products I recommend. If you click a link and buy something I may receive some compensation. This does not change the price you would pay.

News last week of a promising coronavirus vaccine candidate from Pfizer and German firm BioNTech prompted ecstatic headlines. The vaccine was developed in record speed. According to a BioNTech, initial tests show it to be 90% effective at preventing COVID-19 infections. The company also said an external, independent Data Monitoring Committee had reported no “serious safety concerns” regarding the potential vaccine.

One week later, US pharma company Moderna announced its phase 3 vaccine trial with over 30,000 participants showed efficacy to be at 94.5%.

While BioNTech and Pfizer, as well as Moderna, are leading the race to develop a COVID-19 vaccine, other pharma companiessuch as AstraZeneca, Sanofi, Sinovac and Johnson & Johnsonare expected to soon present candidates of their own.

The Coming Pandemic Documentary

A Documentary Produced in 2005 about the Pandemic we are facing now
The Coming Pandemic 2005

According to the World Health Organization, 47 vaccines candidates are currently in clinical trials, of which 10 are in phase 3 efficacy trials. Russia has already registered two vaccines, one of whichSputnik Vbecame available for public use in August. Experts, however, warn that this vaccine has been insufficiently tested.

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

For more news go to: http://www.dw.com/en/
Follow DW on social media:
Facebook: https://www.facebook.com/deutschewellenews/
Twitter: https://twitter.com/dwnews
Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/channel/deutschewelle
#Coronavirus #Vaccine #Moderna

Alternate Health Remedies

Vaccine Update: Who's leading in creating an effective coronavirus vaccine? | DW News

News last week of a promising coronavirus vaccine candidate from Pfizer and German firm BioNTech prompted ecstatic headlines. The vaccine was developed in record speed. According to a BioNTech, initial tests show it to be 90% effective at preventing COVID-19 infections. The company also said an external, independent Data Monitoring Committee had reported no "serious safety concerns" regarding the potential vaccine.

One week later, US pharma company Moderna announced its phase 3 vaccine trial with over 30,000 participants showed efficacy to be at 94.5%.

While BioNTech and Pfizer, as well as Moderna, are leading the race to develop a COVID-19 vaccine, other pharma companies — such as AstraZeneca, Sanofi, Sinovac and Johnson & Johnson — are expected to soon present candidates of their own.

According to the World Health Organization, 47 vaccines candidates are currently in clinical trials, of which 10 are in phase 3 efficacy trials. Russia has already registered two vaccines, one of which — Sputnik V — became available for public use in August. Experts, however, warn that this vaccine has been insufficiently tested.

Subscribe: https://www.youtube.com/user/deutschewelleenglish?sub_confirmation=1

For more news go to: http://www.dw.com/en/
Follow DW on social media:
►Facebook: https://www.facebook.com/deutschewellenews/
►Twitter: https://twitter.com/dwnews
►Instagram: https://www.instagram.com/dwnews
Für Videos in deutscher Sprache besuchen Sie: https://www.youtube.com/channel/deutschewelle
#Coronavirus #Vaccine #Moderna
Topics #biontech #biontech pfizer #biontech vaccine #biontechv accine #Corona #corona news #corona update #corona vaccine #corona virus #Coronavirus #coronavirus news #coronavirus pandemic #coronavirus update #coronavirus vaccination #coronavirus vaccine #coronavirus vaccines #covid-19 #curevac #curevac vaccine #moderna #moderna vaccine #Pandemic #pfizer #pfizer vaccine #sputnik v #vaccine #vaccine breakthrough #vaccine development #vaccine distribution #vaccine production #vaccine race #vaccine update